Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-07

Clinical Trial Update: Insulin Glargine at Bedtime or in AM Versus NPH [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing bedtime or morning administration of insulin glargine versus NPH insulin in adults with Type 2 Diabetes Mellitus has completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humulin N (insulin isophane (NPH))
  • Lantus (insulin glargine)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2010-10-07